Padcev plus Keytruda significantly improves event-free and overall survival in cisplatin-eligible MIBC patients, meeting primary and secondary endpoints in the EV-304 trial. The combination therapy ...

Recurrences of low-, intermediate-, or high-/very high-risk tumors were again low, intermediate, or high risk in 74%, 62%, and 44% of cases, respectively. Recurrent non-muscle invasive bladder cancer ...

A massive water tank belonging to the Kochi Corporation's 45th Division burst early this morning in Thammanam, flooding the area and damaging homes and vehicles. The tank, with a capacity of 1.35 ...

The battlefield in eastern Ukraine has destroyed Ukrainian armor at an alarming rate, and NATO tank deliveries to Kyiv have been unable to close the gap. The Russians are exacting a heavy toll upon ...

An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland. Dr. Heather Chalfin, a urologic ...

We may receive a commission on purchases made from links. The automotive industry is awash with all kinds of alternative fuels for internal combustion engines, from LPG to ethanol, fryer oil to ...

Jake Paul is set to face Gervonta "Tank" Davis in an exhibition boxing match in a little over a month at the Kaseya Center in Miami on Friday, November 14. YouTuber-turned-boxer Paul enters the ring ...

Please provide your email address to receive an email when new articles are posted on . Most patients with non-muscle-invasive bladder cancer who received TAR-200 with gemcitabine achieved complete ...

Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...

NEW YORK CITY — The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of bladder cancer, the drugmaker said on Tuesday, offering a ...